Loss of response and need for adalimumab dose intensification in Crohn's disease: a systematic review

V Billioud, WJ Sandborn… - Official journal of the …, 2011 - journals.lww.com
The objective of this study was to review loss of response and need for adalimumab dose
intensification in adult and pediatric patients with Crohn's disease. Studies were identified …

The London position statement of the world Congress of gastroenterology on biological therapy for IBD with the European Crohn's and colitis organisation: pregnancy …

U Mahadevan, S Cucchiara, JS Hyams… - Official journal of the …, 2011 - journals.lww.com
Women with inflammatory bowel disease (IBD) have similar rates of fertility to the general
population, but have an increased rate of adverse pregnancy outcomes compared with the …

Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease

FM Ruemmele, G Veres, KL Kolho… - Journal of Crohn's …, 2014 - academic.oup.com
Children and adolescents with Crohn's disease (CD) present often with a more complicated
disease course compared to adult patients. In addition, the potential impact of CD on growth …

Japanese guidelines for the management and treatment of generalized pustular psoriasis: the new pathogenesis and treatment of GPP

H Fujita, T Terui, K Hayama, M Akiyama… - The Journal of …, 2018 - Wiley Online Library
Generalized pustular psoriasis (GPP) is a rare disease characterized by recurrent fever and
systemic flushing accompanied by extensive sterile pustules. The committee of the …

Safety and efficacy of adalimumab for moderate to severe Crohn's disease in children

JS Hyams, A Griffiths, J Markowitz, RN Baldassano… - Gastroenterology, 2012 - Elsevier
BACKGROUND & AIMS: The IMAgINE 1 study (NCT00409682) evaluated the safety and
efficacy of adalimumab double-blind maintenance dosing regimens following open-label …

Systematic review: monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD

PS Dulai, CA Siegel, JF Colombel, WJ Sandborn… - Gut, 2014 - gut.bmj.com
Methods To construct this review article, we performed a systematic review of the literature to
identify relevant studies comparing anti-TNF monotherapy to combination therapy with an …

Pediatric inflammatory bowel disease

MA Conrad, JR Rosh - Pediatric Clinics, 2017 - pediatric.theclinics.com
IBD is a chronic immune-mediated condition of the GI tract in which the goal of treatment is
to induce and maintain durable remission. Although classically divided into Crohn disease …

Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor–α inhibitors: systematic …

SS Toussi, N Pan, HM Walters… - Clinical infectious …, 2013 - academic.oup.com
Tumor necrosis factor alpha (TNF-α) inhibitors are increasingly administered to children and
adolescents with juvenile idiopathic arthritis (JIA) and pediatric inflammatory bowel disease …

Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies

F Magro, F Portela - BioDrugs, 2010 - Springer
Inflammatory bowel disease (IBD), most commonly referring to Crohn's disease and
ulcerative colitis, is a chronic and disabling condition with an increasing incidence in …

Adalimumab in the treatment of immune-mediated diseases

G Lapadula, A Marchesoni, A Armuzzi… - International …, 2014 - journals.sagepub.com
Tumour necrosis factor (TNF) plays an important role in the pathogenesis of immune-
mediated inflammatory diseases (IMIDs). TNF inhibition results in down-regulation of …